Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Enzymes Market Size from 2025 to 2034?

The size of the enzymes market has witnessed a swift expansion over the past few years. It is projected to increase from $13.38 billion in 2024 to $15.2 billion in 2025, growing at a compound annual growth rate (CAGR) of 13.6%. Factors contributing to the growth during the historic period include globalization and market expansion, investments in research and development, heightened consumer awareness and demand, advancements in bioprocessing technology, as well as a focus on waste reduction and recycling.

The market size of enzymes is projected to witness substantial growth in the coming years, skyrocketing to $25.34 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 13.6%. The expansion in the projected timeline can be credited to various factors such as the dynamics of market demand, focus on eco-friendly procedures, trends in health and nutrition, biofuel and renewable energy, and new applications. Key trends projected in this time frame involve advancements in biotechnology, demand for sustainability, the surge in demand in the food and beverage industry, expansion of industrial applications, and the consumer tendency towards natural products.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3425&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Enzymes Market?

The enzyme market is anticipated to grow due to the increasing prevalence of digestive disorders. Digestive disorders encompass a variety of health illnesses that impact the digestive system, including common ones like gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes are responsible for breaking down food into smaller molecules that the body can absorb. For example, the National Center for Biotechnology Information (NCBI), a US-based scientific research community resource, reported in October 2022 that the prevalence of irritable bowel syndrome (IBS) in the United States lies between 10% and 15%, with nearly 12% of patients requiring medical treatment in primary care practices due to IBS-related problems. Thus, the increasing prevalence of these disorders is propelling the expansion of the enzyme market.

Which Primary Segments of the Enzymes Market Are Driving Growth and Industry Transformations?

The enzymes market covered in this report is segmented –

1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products

2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications

3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories

Subsegments:

1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase

2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase

3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases

4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules

5) By Chitinase: Plant Chitinase, Microbial Chitinase

6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules

7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase

8) By Ligase: DNA Ligase, RNA Ligase

9) By Other Products: Amylase, Cellulase, Beta-Glucanase, Other Specialty Enzymes

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3425&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Enzymes Market?# Market?

North America was the largest region in the enzymes market in 2024. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Enzymes Market?

Leading businesses in the enzyme industry, such as Chiesi Global Rare Diseases, are progressing on the innovation front by developing products like Lamzede to provide optimized therapeutic solutions for patients. Lamzede, scientifically known as velmanase alfa, is used in remedying alpha-mannosidosis; an uncommon genetic disorder triggered by the lack of functionality in the lysosomal alpha-galactosidase-A enzyme. In May 2023, Chiesi Global Rare Diseases received the FDA’s seal of approval for the usage of Lamzede in treating non-neurological symptoms in mild-to-moderate alpha-mannosidosis patients. The production of Lamzede harnesses recombinant DNA technology to engineer the recombinant form of human alpha-mannosidase in Chinese hamster ovary (CHO) cells. Lamzede also holds the distinction of being the first U.S. FDA-approved enzyme replacement therapy for addressing the non-central nervous system manifestations of alpha-mannosidosis.

View the full report here:

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

What Parameters Are Used to Define the Enzymes Market?

Enzyme refers to a protein that almost usually serves as a biological catalyst. It accelerates a certain chemical reaction in the cell. It is a substance that serves as a catalyst in living things, controlling the speed at which chemical processes take place without undergoing any changes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3425

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model